Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, R. M.
Right arrow Articles by Grant, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, R. M.
Right arrow Articles by Grant, I.

Psychosomatic Medicine, Vol 57, Issue 2 138-147, Copyright © 1995 by American Psychosomatic Society


ORIGINAL ARTICLES

Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. HNRC Group. HIV Neurobehavioral Research Center

RM Kaplan, JP Anderson, TL Patterson, JA McCutchan, JD Weinrich, RK Heaton, JH Atkinson, L Thal, J Chandler and I Grant
Naval Hospital, San Diego, La Jolla, California, USA.

To evaluate the validity of the Quality of Well-Being Scale (QWB) for studies of patients with human immunodeficiency virus (HIV) disease, 514 men were studied who were divided among four categories: Centers for Disease Control and Prevention (CDC) Group A (N = 272), CDC-B (N = 81), CDC-C (N = 47), and uninfected male controls (N = 114). The QWB and a variety of medical, neuropsychological, and biochemical measures were administered to all participants. When QWB scores were broken down by HIV group, the CDC-C group was significantly lower (.614) than the CDC-B (.679), CDC-A (.754), or control group (.801). The difference between Groups CDC-C and CDC-A was about .14 units of well-being, which suggests that individuals lose 1/7 equivalents of 1 well year of life for each year they are in Group CDC-C in comparison to the asymptomatic group (Group CDC-A). In comparison to the controls, this would equal a 1-year of life loss for each seven infected individuals. The QWB was shown to be significantly associated with CD4+ lymphocytes (p < .001), clinician ratings of neuropsychological impairment (p < .04), neurologists ratings of dysfunction (p < .001), and all subscales of the Profile of Mood States. Baseline QWB scores were significant prospective predictors of death over a median follow-up time of 30 months. Multivariate models demonstrated high covariation between predictors of QWB. It was concluded that the QWB is a significant correlate of biological, neuropsychological, neurological, psychiatric, and mortality outcomes for male HIV-infected patients.


This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
S. D. Ramsey, S. D. Sullivan, and R. M. Kaplan
Cost-Effectiveness of Lung Volume Reduction Surgery
Proceedings of the ATS, May 1, 2008; 5(4): 406 - 411.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. M. Kaplan and A. L. Ries
Health-related Quality of Life in Emphysema
Proceedings of the ATS, May 1, 2008; 5(4): 561 - 566.
[Abstract] [Full Text] [PDF]


Home page
Health Aff (Millwood)Home page
S. D. Ramsey and S. D. Sullivan
Evidence, Economics, And Emphysema: Medicare's Long Journey With Lung Volume Reduction Surgery
Health Aff., January 1, 2005; 24(1): 55 - 66.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. M. Kaplan, A. L. Ries, J. Reilly, and Z. Mohsenifar
Measurement of Health-Related Quality of Life in the National Emphysema Treatment Trial
Chest, September 1, 2004; 126(3): 781 - 789.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P.W. Jones and R.M. Kaplan
Methodological issues in evaluating measures of health as outcomes for COPD
Eur. Respir. J., June 1, 2003; 21(41_suppl): 13S - 18s.
[Abstract] [Full Text] [PDF]


Home page
J Aging HealthHome page
T. A. Cronan, E. R. Serber, H. R. Walen, and M. Jaffe
The Influence of Age on Fibromyalgia Symptoms
J Aging Health, August 1, 2002; 14(3): 370 - 384.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. C. ANGUS, A. A. MUSTHAFA, G. CLERMONT, M. F. GRIFFIN, W. T. LINDE-ZWIRBLE, T. T. DREMSIZOV, and M. R. PINSKY
Quality-adjusted Survival in the First Year after the Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med., May 1, 2001; 163(6): 1389 - 1394.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
R. A. Williams, B. L. Brody, R. G. Thomas, R. M. Kaplan, and S. I. Brown
The Psychosocial Impact of Macular Degeneration
Arch Ophthalmol, April 1, 1998; 116(4): 514 - 520.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
M. F Muldoon, S. D Barger, J. D Flory, and S. B Manuck
What are quality of life measurements measuring?
BMJ, February 14, 1998; 316(7130): 542 - 545.
[Abstract] [Full Text]


Home page
J Aging HealthHome page
D. N. Kerner, T. L. Patterson, I. Grant, and R. M. Kaplan
Validity of the Quality of Well-Being Scale for Patients with Alzheimer's Disease
J Aging Health, February 1, 1998; 10(1): 44 - 61.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
T. E. Hughes, R. M. Kaplan, S. J. Coons, J. R. Draugalis, J. A. Johnson, and T. L. Patterson
Construct Validities of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected Patients
Med Decis Making, October 1, 1997; 17(4): 439 - 446.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Psychosomatic Society